Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.

[1]  Z. Salamon,et al.  Interaction of phosphatidylserine synthase from E. coli with lipid bilayers: coupled plasmon-waveguide resonance spectroscopy studies. , 2000, Biophysical journal.

[2]  V. Hruby,et al.  Differential down-regulation of the human δ-opioid receptor by SNC80 and [d-Pen2,d-Pen5]enkephalin , 2000 .

[3]  John C. Lindon,et al.  Encyclopedia of spectroscopy and spectrometry , 2000 .

[4]  V. Hruby,et al.  Differential down-regulation of the human delta-opioid receptor by SNC80 and [D-Pen(2),D-Pen(5)]enkephalin. , 2000, European journal of pharmacology.

[5]  H Luecke,et al.  Structural changes in bacteriorhodopsin during ion transport at 2 angstrom resolution. , 1999, Science.

[6]  R. Quock,et al.  The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. , 1999, Pharmacological reviews.

[7]  Z. Salamon,et al.  Plasmon resonance spectroscopy: probing molecular interactions within membranes. , 1999, Trends in biochemical sciences.

[8]  Surface Plasmon Resonance, Theory , 1999 .

[9]  Z. Salamon,et al.  Surface Plasmon Resonance, Applications , 1999 .

[10]  Z. Salamon,et al.  Coupled plasmon-waveguide resonance spectroscopy studies of the cytochrome b6f/plastocyanin system in supported lipid bilayer membranes. , 1998, Biophysical journal.

[11]  A. Lomize,et al.  Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. , 1998, Biophysical journal.

[12]  B. Kobilka,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[13]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[14]  H Weinstein,et al.  Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.

[15]  H. Macleod,et al.  Coupled plasmon-waveguide resonators: a new spectroscopic tool for probing proteolipid film structure and properties. , 1997, Biophysical journal.

[16]  H A Macleod,et al.  Surface plasmon resonance spectroscopy as a tool for investigating the biochemical and biophysical properties of membrane protein systems. I: Theoretical principles. , 1997, Biochimica et biophysica acta.

[17]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[18]  J. Tucker,et al.  Purification of a rat neurotensin receptor expressed in Escherichia coli. , 1996, The Biochemical journal.

[19]  Z. Salamon,et al.  Surface plasmon resonance spectroscopy studies of membrane proteins: transducin binding and activation by rhodopsin monitored in thin membrane films. , 1996, Biophysical journal.

[20]  G. Gimpl,et al.  Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification. , 1996, European journal of biochemistry.

[21]  C. Nicolini,et al.  Characterization of Langmuir-Blodgett films of rhodopsin: thermal stability studies. , 1995, Biophysical journal.

[22]  T. Kenakin,et al.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. , 1995, Trends in pharmacological sciences.

[23]  G. Schertler,et al.  Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. , 1995, Biophysical journal.

[24]  P. Portoghese,et al.  Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists. , 1995, Journal of medicinal chemistry.

[25]  R. Raffa,et al.  Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Macleod,et al.  Conformational changes in rhodopsin probed by surface plasmon resonance spectroscopy. , 1994, Biochemistry.

[27]  G. Bell,et al.  Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. , 1994, Molecular pharmacology.

[28]  R J Knapp,et al.  Identification of a human delta opioid receptor: cloning and expression. , 1994, Life sciences.

[29]  Gebhard F. X. Schertler,et al.  Projection structure of rhodopsin , 1993, Nature.

[30]  D Rodbard,et al.  Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. , 1992, Molecular pharmacology.

[31]  J. Saavedra,et al.  Heterogeneity of angiotensin II AT2 receptors in the rat brain. , 1992, Molecular pharmacology.

[32]  T. Kenakin.  Drugs and receptors. An overview of the current state of knowledge. , 1990, Drugs.

[33]  V. Hruby,et al.  Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T F Burks,et al.  Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  H C Hemker,et al.  The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry. , 1983, The Journal of biological chemistry.

[36]  D. O. Rudin,et al.  Reconstitution of Cell Membrane Structure in vitro and its Transformation into an Excitable System , 1962, Nature.